The 'perfect use' failure rate of the combined oral contraceptive pill (COCP) is 0.3 per 100 woman-years, while the 'typical use' failure rate is 9 per 100 woman-years. This discrepancy is primarily attributed to:

• A Enzymatic induction by concomitant medications reducing pill efficacy
• B Differences in bioavailability of estrogen formulations between brands
• C Individual variation in CYP450 enzyme activity affecting drug metabolism
• D Inconsistent or incorrect use (missed pills, delayed starts, drug interactions) in real-world settings ✓

Explanation

The difference between 'perfect use' (method failure rate under ideal, consistent, correct use) and 'typical use' (user failure rate including human error in real-world settings) for the COCP is primarily due to inconsistent or incorrect use — missed pills, late pill starts, vomiting within 2 hours of taking a pill, or failure to use backup methods. Pearl Index measures typical-use failure rate. The theoretical (perfect use) efficacy of COCPs is 99.7%, but typical-use efficacy drops to about 91% (9% failure rate). Drug interactions (e.g., rifampicin, phenytoin) do reduce efficacy but account for a much smaller proportion of failures compared to user compliance issues.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.